Showing results (81-90 of 636) with videos related to

Sort By:
Pageof 64
Urology|November 1, 1978
Cell-mediated immunity in patients with renal cell carcinoma as measured by leukocyte migration inhibition testG L Wright, P F Schellhammer, F E Rosato, et al.
Urology|April 1, 1993
Reevaluation of prostate biopsy after definitive radiation therapyE B Miller, L E Ladaga, A M el-Mahdi, et al.
Cancer|August 15, 1985
The effect of transurethral prostatic resection on the incidence of osseous prostatic metastasisD A Kuban, A M el-Mahdi, P F Schellhammer, et al.
Urology|May 1, 1979
Transitional cell carcinoma: cause of refractory cancer of prostateJ R Wendelken, P F Schellhammer, L E Ladaga, et al.
Urology|March 4, 2000
Does prolonged combined androgen blockade have survival benefits over short-term combined androgen blockade therapy?M F Sarosdy, P F Schellhammer, R Johnson, et al.
The Journal of Urology|October 1, 1985
Cancer serum index and prostatic acid phosphatase for detection of progressive prostatic cancerE L Robey, P F Schellhammer, G L Wright, et al.
The Urologic Clinics of North America|May 1, 1997
Prostate-specific antigen after radiation therapy. Prognosis by pretreatment level and post-treatment nadirP F Schellhammer, A M el-Mahdi, D A Kuban, et al.
The Prostate|January 1, 1993
Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinomaC L Huang, D Brassil, M Rozzell, et al.
Radiology|February 1, 1995
Carcinoma of the prostate: race as a prognostic indicator in definitive radiation therapyJ A Kim, D A Kuban, A M el-Mahdi, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1984
Triple course external beam radiotherapy for carcinoma of the prostateA M El-Mahdi, C I Turalba, P F Schellhammer, et al.
Pageof 64